HR 7235, the "Protecting Motherhood Act," requires all federal agencies to stop using the term "birthing person" in official documents and instead use specific terms like "female," "mother," "pregnant woman," or "woman." It directly affects federal agencies that produce regulations, forms, or communications, mandating the use of these defined terms when referring to individuals based on biological sex. The bill provides detailed definitions for terms like "female" (based on biological sex at conception) and "pregnant woman" (an adult human female carrying a child). The law takes effect 30 days after enactment. This is a procedural change focused solely on terminology in government documents, with no direct impact on healthcare access or services.
HR 7200, the VERIFY CDL Act, requires states to verify an applicant's U.S. employment authorization through the E-Verify system before issuing or renewing a commercial driver's license (CDL). This applies directly to individuals seeking a CDL or its renewal, mandating that their work authorization be confirmed via E-Verify at the time of application. The bill amends federal law to make E-Verify verification a condition for CDL issuance or renewal, replacing any existing state-level requirements for this check. It does not alter E-Verify's operation but integrates it into the CDL process for all states adopting the requirement.
HR 6794, the VA Medical Center Facility Transparency Act, requires VA medical facilities to schedule appointments during the same phone call when a covered veteran (enrolled in VA's patient system) requests one. It mandates annual and quarterly public fact sheets from each facility detailing patient statistics, satisfaction ratings, wait times, facility achievements, and areas needing improvement. The bill also requires VA to notify Congress within 90 days when a medical center director is detailed to another position and to appoint an acting director within 120 days. All provisions expire three years after enactment.
HCONRES 68 would require the President to remove U.S. military forces from Venezuela unless Congress has explicitly authorized their use through a declaration of war or a specific law. This applies to any U.S. Armed Forces currently stationed in Venezuela without such authorization. The resolution is based on the War Powers Resolution, which mandates congressional oversight of military deployments. It directs the immediate withdrawal of unapproved forces without adding new time limits or conditions.
This procedural resolution (HRES 1016) directs the House Clerk to correct a technical error in the official version (engrossment) of H.R. 7147. Specifically, it requires changing the wording in section 230(b) from "in this Act or any other act" to "for the Department of Homeland Security in this or any prior Act." The correction is purely administrative and affects only the text of H.R. 7147, with no substantive policy change. It does not impact constituents, create new laws, or alter legislative outcomes.
HR 7212 establishes a federal regulatory framework under the Food, Drug, and Cosmetic Act for "cannabinoid hemp products," directly affecting their manufacturers, distributors, retailers, and consumers. It mandates FDA registration for facilities and product listing, along with adherence to new manufacturing, testing, and labeling requirements for oral, inhalable, and topical cannabinoid hemp products. Key provisions include setting cannabinoid content limits, prohibiting certain ingredients and marketing practices (like appealing to children), requiring child-resistant packaging, and establishing a minimum purchase age of 21. The bill grants the FDA authority to enforce these rules through mandatory recalls, refusal of non-compliant imports, and penalties for violations, including selling "prohibited cannabinoid products" or to underage individuals. Additionally, it creates an advisory committee to provide recommendations on cannabinoid content limits and other regulatory matters.
This bill creates a tax credit for businesses selling products made with U.S.-grown cotton. The credit equals 24% of the cotton's market value if processed only in the U.S. or in countries with U.S. trade deals, or 18% for other processing locations. To qualify, cotton must be digitally traced from U.S. farms to finished products and certified by the USDA as meeting origin requirements. It directly affects clothing and textile manufacturers selling qualifying products in the U.S. market.
HR 7190 would end immigration detention and electronic monitoring by requiring the immediate release of all detained noncitizens on their own recognizance within six months and repealing all federal laws authorizing detention. It prohibits using federal funds for detention facilities, ankle monitors, or immigration enforcement activities after specific deadlines (six months for monitors, two years for detention contracts). Instead, it establishes a new grant program to fund community-based wrap-around services - including housing, healthcare, mental health support, legal aid, and job training - provided voluntarily by non-profit organizations without surveillance or data sharing with federal agencies. The bill directly affects noncitizens currently held in detention or under electronic monitoring.
HR 4255, the Enhancing Safety for Animals Act of 2025, would remove the Mexican wolf (Canis lupus baileyi) from the U.S. Endangered Species Act protections. It directly affects ranchers in the Mexican Wolf Experimental Population Area, who report livestock losses and safety concerns, and shifts regulatory authority from the U.S. Fish and Wildlife Service to state and local management. Key provisions include formally delisting the wolf, nullifying two existing federal rules governing the species, and prohibiting future consideration of Mexican wolf populations in Mexico when making ESA decisions. The bill aims to streamline livestock compensation for ranchers by changing evidentiary standards for wolf depredation claims.
HR 7178, the U.S.-Israel Anti-Killer Drone Act of 2026, requires enhanced U.S.-Israel cooperation to counter Iranian unmanned systems. The bill directs the U.S. and Israel to jointly develop, test, and deploy counter-drone technologies through their existing Operations Technology-Working Group, including sharing threat intelligence and conducting joint training. It increases annual funding for this cooperation from $55 million to $100 million and mandates detailed annual reports to Congress on progress, threat assessments, and the adequacy of current counter-drone capabilities. The bill directly affects U.S. and Israeli military forces by accelerating joint efforts to address threats from Iran-origin drones targeting U.S. allies and military assets in the Middle East.
HR 7177, the Protecting Girls with Turner Syndrome Act of 2026, prohibits abortions performed specifically because of a prenatal diagnosis or test result indicating Turner syndrome (a chromosomal condition involving missing or partially missing X chromosomes). It requires healthcare providers to ask pregnant women about such diagnoses before performing abortions and to inform them of the prohibition. Violations could lead to criminal penalties (up to 5 years in prison) or civil lawsuits allowing affected parties - such as the woman, father, or maternal grandparent - to seek damages, including punitive awards. The bill also mandates privacy protections for women involved in such cases and requires medical professionals to report suspected violations.
The PrEP Access Act expands Medicare Part B coverage to include pharmacist-provided HIV prevention services, such as pre-exposure prophylaxis (PrEP) counseling, medication administration, and related testing. It directly affects Medicare beneficiaries (primarily seniors) and pharmacists, allowing pharmacists to bill Medicare for these services under state law. Key provisions set payment at 80% of the lesser of actual charges or 85% of physician rates, and prohibit balance billing for these services. The policy change takes effect January 1, 2027, making PrEP more accessible through pharmacy settings.
